The introduction of TNF-a blocking agents is one of the milestones in the therapy of rheumatoid arthritis, parallel to the introduction of cortico-steroids. Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, the book charts the history and development of the concept of tumor-necrosis-factor-alpha (TNF-a) inhibition. The authors document TNF-a from its discovery to its now well-documented clinical applications in the treatment of patients with rheumatoid arthritis. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source for the most recent information in this field.
具体描述
读后感
评分
评分
评分
评分
用户评价
相关图书
本站所有内容均为互联网搜索引擎提供的公开搜索信息，本站不存储任何数据与内容，任何内容与数据均与本站无关，如有需要请联系相关搜索引擎包括但不限于百度，google,bing,sogou 等
© 2025 book.wenda123.org All Rights Reserved. 图书目录大全 版权所有